v3.25.4
Consolidated Balance Sheets - USD ($)
Sep. 30, 2025
Sep. 30, 2024
Current Assets:    
Cash and cash equivalents $ 3,924,908 $ 112
Inventory 22,286,693 8,268,766
Prepaid expenses 1,331,280 2,700,000
Total Current Assets 27,542,881 10,968,878
Other Assets:    
In-process research and development 73,400,000 73,400,000
Total Other Assets 73,400,000 73,400,000
Total Assets 100,942,881 84,368,878
Current Liabilities:    
Accounts payable 13,234,684 3,711,622
License payable 22,650,000 28,400,000
Accrued expenses 4,093,124
Total Current Liabilities 49,491,579 32,700,429
Deferred tax liability 2,784,960 1,728,000
Total Liabilities 56,076,650 38,228,540
Stockholders’ Equity:    
Preferred stock - $0.0001 par value; 10,000,000 shares authorized: no shares issued and outstanding
Common stock - $0.0001 par value; 400,000,000 and 100,000,000 shares authorized at September 30, 2025 and 2024, respectively; 83,513,442 and 71,552,402 shares issued and outstanding at September 30, 2025 and 2024, respectively 8,351 7,155
Additional paid-in capital 108,897,836 85,411,771
Accumulated deficit (64,039,956) (39,278,587)
Total Stockholders’ Equity 44,866,231 46,140,339
Total Liabilities and Stockholders’ Equity 100,942,881 84,368,878
Related Party    
Current Liabilities:    
Due to related party 9,513,771 588,806
Note payable to related party $ 3,800,111 $ 3,800,111